Organon & Co (OGN)

28.83
-0.84(-2.83%)
After Hours
28.83
0.00(0.00%)
- Real-time Data
  • Volume:
    2,416,093
  • Bid/Ask:
    28.70/28.89
  • Day's Range:
    28.50 - 29.79

OGN Overview

Prev. Close
29.67
Day's Range
28.5-29.79
Revenue
4.7B
Open
29.68
52 wk Range
27.37-38.75
EPS
-
Volume
2,416,093
Market Cap
7.31B
Dividend (Yield)
1.12
(3.77%)
Average Volume (3m)
1,929,974
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
253,550,029
Next Earnings Date
23 Feb 2022
What is your sentiment on Organon & Co?
or
Market is currently closed. Voting is open during market hours.

Organon & Co Company Profile

Employees
0

Organon & Co., a science-based pharmaceutical company, develops and delivers health solutions through a portfolio of prescription therapies within women’s health, biosimilars, and established brands. Its women’s health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company’s biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio in the United States, Canada, Australia, and Ukraine. It also has a portfolio of established brands in cardiovascular, respiratory, dermatology, and non-opioid pain management. The company sells its products primarily to drug wholesalers and retailers, hospitals, government agencies, and managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey. Organon & Co. operates independently of Merck & Co., Inc. as of June 2, 2021.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellStrong SellSell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellBuy
SummaryStrong BuyNeutralStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.